106 related articles for article (PubMed ID: 17266643)
41. Overstimulation of PrPC signaling pathways by prion peptide 106-126 causes oxidative injury of bioaminergic neuronal cells.
Pietri M; Caprini A; Mouillet-Richard S; Pradines E; Ermonval M; Grassi J; Kellermann O; Schneider B
J Biol Chem; 2006 Sep; 281(38):28470-9. PubMed ID: 16864581
[TBL] [Abstract][Full Text] [Related]
42. Expression of the Prion Protein Family Member Shadoo Causes Drug Hypersensitivity That Is Diminished by the Coexpression of the Wild Type Prion Protein.
Nyeste A; Bencsura P; Vida I; Hegyi Z; Homolya L; Fodor E; Welker E
J Biol Chem; 2016 Feb; 291(9):4473-86. PubMed ID: 26721882
[TBL] [Abstract][Full Text] [Related]
43. Deletion of N-terminal residues 23-88 from prion protein (PrP) abrogates the potential to rescue PrP-deficient mice from PrP-like protein/doppel-induced Neurodegeneration.
Atarashi R; Nishida N; Shigematsu K; Goto S; Kondo T; Sakaguchi S; Katamine S
J Biol Chem; 2003 Aug; 278(31):28944-9. PubMed ID: 12759361
[TBL] [Abstract][Full Text] [Related]
44. The neurotoxicity of prion protein (PrP) peptide 106-126 is independent of the expression level of PrP and is not mediated by abnormal PrP species.
Fioriti L; Quaglio E; Massignan T; Colombo L; Stewart RS; Salmona M; Harris DA; Forloni G; Chiesa R
Mol Cell Neurosci; 2005 Jan; 28(1):165-76. PubMed ID: 15607951
[TBL] [Abstract][Full Text] [Related]
45. Resistance of cell lines to prion toxicity aided by phospho-ERK expression.
Uppington KM; Brown DR
J Neurochem; 2008 May; 105(3):842-52. PubMed ID: 18088369
[TBL] [Abstract][Full Text] [Related]
46. Autophagy induced by resveratrol prevents human prion protein-mediated neurotoxicity.
Jeong JK; Moon MH; Bae BC; Lee YJ; Seol JW; Kang HS; Kim JS; Kang SJ; Park SY
Neurosci Res; 2012 Jun; 73(2):99-105. PubMed ID: 22465415
[TBL] [Abstract][Full Text] [Related]
47. Copper is required for prion protein-associated superoxide dismutase-I activity in Pichia pastoris.
Treiber C; Pipkorn R; Weise C; Holland G; Multhaup G
FEBS J; 2007 Mar; 274(5):1304-11. PubMed ID: 17263729
[TBL] [Abstract][Full Text] [Related]
48. Copper and zinc promote interactions between membrane-anchored peptides of the metal binding domain of the prion protein.
Kenward AG; Bartolotti LJ; Burns CS
Biochemistry; 2007 Apr; 46(14):4261-71. PubMed ID: 17371047
[TBL] [Abstract][Full Text] [Related]
49. Core structure of amyloid fibrils formed by residues 106-126 of the human prion protein.
Walsh P; Simonetti K; Sharpe S
Structure; 2009 Mar; 17(3):417-26. PubMed ID: 19278656
[TBL] [Abstract][Full Text] [Related]
50. Prion protein region 23-32 interacts with tubulin and inhibits microtubule assembly.
Osiecka KM; Nieznanska H; Skowronek KJ; Karolczak J; Schneider G; Nieznanski K
Proteins; 2009 Nov; 77(2):279-96. PubMed ID: 19422054
[TBL] [Abstract][Full Text] [Related]
51. Calcium binding promotes prion protein fragment 90-231 conformational change toward a membrane destabilizing and cytotoxic structure.
Sorrentino S; Bucciarelli T; Corsaro A; Tosatto A; Thellung S; Villa V; Schininà ME; Maras B; Galeno R; Scotti L; Creati F; Marrone A; Re N; Aceto A; Florio T; Mazzanti M
PLoS One; 2012; 7(7):e38314. PubMed ID: 22811758
[TBL] [Abstract][Full Text] [Related]
52. Fusion of Doppel to octapeptide repeat and N-terminal half of hydrophobic region of prion protein confers resistance to serum deprivation.
Lee DC; Sakudo A; Kim CK; Nishimura T; Saeki K; Matsumoto Y; Yokoyama T; Chen SG; Itohara S; Onodera T
Microbiol Immunol; 2006; 50(3):203-9. PubMed ID: 16547418
[TBL] [Abstract][Full Text] [Related]
53. Different structural stability and toxicity of PrP(ARR) and PrP(ARQ) sheep prion protein variants.
Paludi D; Thellung S; Chiovitti K; Corsaro A; Villa V; Russo C; Ianieri A; Bertsch U; Kretzschmar HA; Aceto A; Florio T
J Neurochem; 2007 Dec; 103(6):2291-300. PubMed ID: 17919292
[TBL] [Abstract][Full Text] [Related]
54. Curative properties of antibodies against prion protein: a comparative in vitro study of monovalent fragments and divalent antibodies.
Alexandrenne C; Hanoux V; Dkhissi F; Boquet D; Couraud JY; Wijkhuisen A
J Neuroimmunol; 2009 Apr; 209(1-2):50-6. PubMed ID: 19232746
[TBL] [Abstract][Full Text] [Related]
55. The novel sorting nexin SNX33 interferes with cellular PrP formation by modulation of PrP shedding.
Heiseke A; Schöbel S; Lichtenthaler SF; Vorberg I; Groschup MH; Kretzschmar H; Schätzl HM; Nunziante M
Traffic; 2008 Jul; 9(7):1116-29. PubMed ID: 18419754
[TBL] [Abstract][Full Text] [Related]
56. Cellular pathogenesis in prion diseases.
Crozet C; Beranger F; Lehmann S
Vet Res; 2008; 39(4):44. PubMed ID: 18413130
[TBL] [Abstract][Full Text] [Related]
57. Neurotoxicity of prion peptide 106-126 not confirmed.
Kunz B; Sandmeier E; Christen P
FEBS Lett; 1999 Sep; 458(1):65-8. PubMed ID: 10518935
[TBL] [Abstract][Full Text] [Related]
58. A deleted prion protein that is neurotoxic in vivo is localized normally in cultured cells.
Christensen HM; Harris DA
J Neurochem; 2009 Jan; 108(1):44-56. PubMed ID: 19046329
[TBL] [Abstract][Full Text] [Related]
59. Rutin alleviates prion peptide-induced cell death through inhibiting apoptotic pathway activation in dopaminergic neuronal cells.
Na JY; Kim S; Song K; Kwon J
Cell Mol Neurobiol; 2014 Oct; 34(7):1071-9. PubMed ID: 25048806
[TBL] [Abstract][Full Text] [Related]
60. BCL-2 counteracts Doppel-induced apoptosis of prion-protein-deficient Purkinje cells in the Ngsk Prnp(0/0) mouse.
Heitz S; Gautheron V; Lutz Y; Rodeau JL; Zanjani HS; Sugihara I; Bombarde G; Richard F; Fuchs JP; Vogel MW; Mariani J; Bailly Y
Dev Neurobiol; 2008 Feb; 68(3):332-48. PubMed ID: 18085563
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
